Abstract
Background Left bundle branch pacing (LBBP) in bipolar pacing produces a more balanced ventricular activation than conventional unipolar pacing but need high pacing output. The present study aimed to compare the electrophysiological characteristics of LBBP in different bilateral electrode pacing vector configurations.
Methods A total of 57 patients who met the criteria for left bundle branch (LBB) capture and underwent three bilateral electrode pacing vector configuration test were enrolled. The electrocardiogram (ECG) and electrogram (EGM) parameters were evaluated and other electrophysiological characteristics were analyzed using a three-electrode configuration test.
Results Seven capture modes (right ventricular septal (RVS) + left ventricular septal (LVS) + LBB, RVS + LBB, LVS + LBB, RVS + LVS, RVS, LVS, and LBB) were utilized in the study. The thresholds of full fusion mode (RVS+LVS+LB) in Bilateral Cathodes and Ring Bipolar were all lower than that in Tip Bipolar (1.2 ± 0.5 V vs. 2.7 ± 1.0 V, P < 0.001; 1.6 ± 0.6 V vs. 2.7 ± 1.0 V, P < 0.001). Full fusion mode had the shortest P-QRS (116.9 ± 12.8 ms), V6 RWPT (64.9 ± 9.7 ms), and V1 RWPT (94.5 ± 12.3 ms).
Conclusion Changing the bilateral electrode pacing vector configuration to Bilateral Cathodes and Ring Bipolar can reduce the full fusion mode capture threshold compared to conventional bipolar pacing.
What is Known?
Left bundle branch pacing in bipolar pacing can capture left bundle branch, left ventricular septal myocardial, and right ventricular septal myocardial at a higher pacing output, which was termed full fusion mode.
What the Study Adds?
This study indicates that the full fusion mode threshold can be reduced by changing the pacing vector configuration.
Seven capture modes were observed in Ring Bipolar and Bilateral Cathodes during threshold testing.
The characteristics of ECG and EGM of different types of capture in three bilateral electrode pacing vector configurations and the schematic representation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The study protocol was approved by the hospital institutional review board (SL-KYSB-NBEY-2021-079-01)
Funding Statement
This work was supported by the Zhejiang Provincial Public Service and Application Research Foundation, China [grant number LGF22H020009], the Ningbo Health Branding Subject Fund [grant number PPXK2018-01] and Medical Scientific Research Foundation of Zhejiang Province, China [grant number 2022KY1122].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ningbo NO.2 Hospital institutional review board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflict of interest statement: we declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.
Funding sources: This work was supported by the Zhejiang Provincial Public Service and Application Research Foundation, China [grant number LGF22H020009], the Ningbo Health Branding Subject Fund [grant number PPXK2018-01] and Medical Scientific Research Foundation of Zhejiang Province, China [grant number 2022KY1122].
Data Availability
The data that support the findings of this study are available from the corresponding author, Longfu Jiang, MD, upon reasonable request.
